B. Braun to open new Renal Care Centre in Portlaoise
B. Braun Avitum have been awarded a contract by the HSE to develop and operate a new state-of-the-art Satellite Renal
Read more
Clinical
Ireland 14th in skin cancer global risk table
A new global table of skin cancer susceptibility has revealed that Ireland has the 14th highest rate in the world.
Read more
New guideline launched to improve the quality and safety of treating Type 1 Diabetes
The first ever National Clinical Guideline for Adults living with Type 1 Diabetes has been launched in Ireland. The publication
Read more
Loci Orthopaedics raises €2.75m in funding
NUI Galway-based medical device spin-out company, Loci Orthopaedics have announced the closing of a €2.75 million seed round investment to
Read more
Pause in the use of Transvaginal Mesh Devices
The Minister for Health Simon Harris TD has announced that the Department’s Chief Medical Officer (CMO) Dr. Tom O’Connell has
Read more
Minister for Health launches new online information repository on medical cannabis
The Minister for Health Simon Harris has published a new online repository of information on medical cannabis on the Department
Read more
New guideline launched to improve the quality and safety of treating Type 1 Diabetes
Minister for Health, Simon Harris has launched a new guideline aimed at improving the quality and safety of treating Type
Read more
Minister Daly confirms appointment of 10 new ANP’s to Mental Health Services
Jim Daly TD, Minister for Mental Health, held a special meeting this week with the nine Chief Officers of the HSE to review existing CAMHS provision, and to see how this might be strengthened in the future. This initiative
Read more
Saint-Gobain acquires Dublin pharma business
Saint-Gobain’s Performance Plastics Life Sciences business has acquired the pharmaceutical business of Micro Hydraulics, Ltd., a Dublin, Ireland, based supplier
Read more
Study published in The Lancet shows new treatment for later stage multiple sclerosis significantly improves outcomes
Novartis has announced that the full results from the EXPAND study of siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS)
Read more